Supernus Pharmaceuticals, Inc.SUPNNASDAQ
LOADING
|||
Switch Symbol:
Revenue Performance
Above historical average, strong compound growth.
Left:
||||
Total revenue from sales of goods and services
Latest
$661.82M
↑ 47% above average
Average (9y)
$450.01M
Historical baseline
Range
High:$667.24M
Low:$144.43M
CAGR
+18.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $661.82M | +8.9% |
| 2023 | $607.52M | -8.9% |
| 2022 | $667.24M | +15.1% |
| 2021 | $579.77M | +11.4% |
| 2020 | $520.40M | +32.5% |
| 2019 | $392.75M | -3.9% |
| 2018 | $408.90M | +35.3% |
| 2017 | $302.24M | +40.6% |
| 2016 | $215.00M | +48.9% |
| 2015 | $144.43M | - |